about
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesA multifunctional 3D co-culture system for studies of mammary tissue morphogenesis and stem cell biology.Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.Stat3 is required to maintain the full differentiation potential of mammary stem cells and the proliferative potential of mammary luminal progenitors.Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma.Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma.Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival.Cannabinoids: a new hope for breast cancer therapy?Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer.Aberrant expression of MicroRNAs in B-cell lymphomas.Regulation of human genome expression and RNA splicing by human papillomavirus 16 E2 protein.Depletion of HPV16 early genes induces autophagy and senescence in a cervical carcinogenesis model, regardless of viral physical state.Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation.JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells.Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma.Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer
P50
Q26748881-55EF6E9B-D73B-499C-910E-2166799FE57BQ34044978-39548AF3-B5A2-403A-978A-5C252D29C672Q34049715-2D97A06B-E96F-470A-8144-BBC2BB24EB60Q34070354-6AE0C37C-B5D5-4322-8414-A4A6EC1A0D18Q34534230-4B5039B5-CE9D-4CE0-8B1F-6A2E24960A0AQ34658788-8C58D055-172B-4FE4-BEBE-0A58DA3DC255Q34891045-1AB0A0B3-D48B-425F-A507-9C37184B31D2Q37100743-A8A8D1BB-F562-43EA-850F-4F70B5843151Q38024891-83D34F96-87CA-499B-AB79-79656C9B5D9CQ38889500-6F7DAAE7-3955-41EB-B3C5-0E22B72545F2Q38939240-497B0F4D-ED4B-4617-9F01-391CC543CE8BQ38965368-6189337C-43D9-4C0A-BB53-32B9903928BFQ39115549-E931D849-7A12-4951-A690-444678DE86A0Q40259864-2324138A-4A2D-4D21-A154-7C742802D85BQ46613967-03AAD211-140B-4284-9C92-7779736CB682Q47368243-05658FBE-A4A2-450A-A186-11A4DEC91741Q91409346-D3F74E12-475E-4866-BF8C-DF18824003F0
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-7442-6827
@en
name
Maria M Caffarel
@ast
Maria M Caffarel
@en
Maria M Caffarel
@es
Maria M Caffarel
@nl
type
label
Maria M Caffarel
@ast
Maria M Caffarel
@en
Maria M Caffarel
@es
Maria M Caffarel
@nl
prefLabel
Maria M Caffarel
@ast
Maria M Caffarel
@en
Maria M Caffarel
@es
Maria M Caffarel
@nl
P106
P1153
24821121100
P21
P31
P496
0000-0002-7442-6827